Healthcare - Sector
KYMR is currently covered by 23 analysts with an average price target of $134.86. This is a potential upside of $19.55 (16.95%) from yesterday's end of day stock price of $115.31.
Kymera Therapeutics's activity chart (see below) currently has 219 price targets and 214 ratings on display. The stock rating distribution of KYMR is 96.36% BUY and 3.64% HOLD.
Analysts' price targets on this stock were met 93.79% of the time, taking 295.32 days on average.
Highest price target for KYMR is $170, Lowest price target is $97, average price target is $134.86.
Most recent stock forecast was given by ELIANA MERLE from BARCLAYS on 02-Nov-2026. First documented stock forecast 15-Sep-2020.
Currently out of the existing stock ratings of KYMR, 53 are a BUY (96.36%), 2 are a HOLD (3.64%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-May-2021
$170
$54.69 (47.43%)
$139
19 days ago
(02-Nov-2026)
6/8 (75%)
$42.49 (33.32%)
459
Hold Since 30-Oct-2026
$116
$0.69 (0.60%)
$115
22 days ago
(30-Oct-2026)
5/5 (100%)
$-10.63 (-8.39%)
84
Buy Since 30-Jun-2023
$150
$34.69 (30.08%)
$136
22 days ago
(30-Oct-2026)
13/14 (92.86%)
$23.37 (18.46%)
192
Buy Since 27-Oct-2026
$146
$30.69 (26.62%)
$79
25 days ago
(27-Oct-2026)
2/3 (66.67%)
$28.43 (24.18%)
97
Buy Since 27-Jun-2025
$150
$34.69 (30.08%)
$120
1 months 16 days ago
(05-Oct-2026)
9/10 (90%)
$40.15 (36.55%)
125
What is KYMR (Kymera Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on KYMR (Kymera Therapeutics)?
Which analyst has the most public recommendations on KYMR (Kymera Therapeutics)?
Which analyst is the currently most bullish on KYMR (Kymera Therapeutics)?
Which analyst is the currently most reserved on KYMR (Kymera Therapeutics)?